SCFD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.255400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.161400E-01
Normal-vs-Stage2
7.752200E-01
Normal-vs-Stage3
4.918400E-01
Normal-vs-Stage4
1.450780E-01
Stage1-vs-Stage2
6.769400E-01
Stage1-vs-Stage3
1.400800E-01
Stage1-vs-Stage4
1.853400E-01
Stage2-vs-Stage3
2.535200E-01
Stage2-vs-Stage4
8.566200E-02
Stage3-vs-Stage4
4.009700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.073200E-01
Normal-vs-AfricanAmerican
5.024800E-01
Normal-vs-Asian
5.312200E-01
Caucasian-vs-AfricanAmerican
4.992600E-01
Caucasian-vs-Asian
6.498200E-02
AfricanAmerican-vs-Asian
9.814500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.607000E-01
Normal-vs-Female
6.846800E-01
Male-vs-Female
4.555200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.991000E-01
Normal-vs-Age(41-60Yrs)
5.631400E-01
Normal-vs-Age(61-80Yrs)
8.847600E-01
Normal-vs-Age(81-100Yrs)
3.799800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.123900E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.515000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.152640E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.347600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.310400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.394800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.289800E-01
Normal-vs-Daily Drinker
9.873000E-01
Normal-vs-Weekly Drinker
7.202400E-01
Normal-vs-Occasional Drinker
6.671600E-01
Normal-vs-Social Drinker
5.062200E-01
Non Drinker-vs-Daily Drinker
8.642800E-01
Non Drinker-vs-Weekly Drinker
5.071200E-01
Non Drinker-vs-Occasional Drinker
4.928200E-01
Non Drinker-vs-Social Drinker
1.665420E-01
Daily Drinker-vs-Weekly Drinker
4.585000E-01
Daily Drinker-vs-Occasional Drinker
3.874400E-01
Daily Drinker-vs-Social Drinker
1.767220E-01
Weekly Drinker-vs-Occasional Drinker
7.603200E-01
Weekly Drinker-vs-Social Drinker
8.492600E-01
Occasional Drinker-vs-Social Drinker
4.628000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.166600E-01
Normal-vs-Grade 2
7.143200E-01
Normal-vs-Grade 3
7.335200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.470600E-01
Grade 1-vs-Grade 3
6.021800E-01
Grade 1-vs-Grade 4
7.166600E-01
Grade 2-vs-Grade 3
3.013600E-01
Grade 2-vs-Grade 4
7.143200E-01
Grade 3-vs-Grade 4
7.335200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.585800E-01
Normal-vs-NonDiabetic
7.562400E-01
Diabetic-vs-NonDiabetic
4.969200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.786600E-01
Normal-vs-NoPancreatitis
7.374200E-01
Pancreatitis-vs-NoPancreatitis
3.708800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.117200E-01
Normal-vs-N1
7.273600E-01
N0-vs-N1
7.722000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.986000E-01
Normal-vs-TP53-NonMutant
6.763200E-01
TP53-Mutant-vs-TP53-NonMutant
6.422800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
